DiscoverPrimary Care UpdateEpisode 166: vaping cessation, BP meds and dementia, SGLT-2's, and AI for melanoma
Episode 166: vaping cessation, BP meds and dementia, SGLT-2's, and AI for melanoma

Episode 166: vaping cessation, BP meds and dementia, SGLT-2's, and AI for melanoma

Update: 2024-10-23
Share

Description

Join Gary, Kate, Mark and Henry as they discuss text messages for adolescent vaping cessation, stopping BP meds in nursing home residents with dementia, the benefits of SGLT-2 inhibitors, and mobile phone app–based artificial intelligence for diagnosing melanoma.


Click here for transcript, notes and links for this episode.



Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 166: vaping cessation, BP meds and dementia, SGLT-2's, and AI for melanoma

Episode 166: vaping cessation, BP meds and dementia, SGLT-2's, and AI for melanoma

Mark Ebell